Journal ArticleJ Am Coll Cardiol · August 6, 2024
BACKGROUND: For many patients, sudden cardiac arrest (SCA) risk is elevated temporarily. Wearable cardioverter-defibrillators (WCDs) can monitor and treat SCA during these temporary periods. Traditional WCDs can be uncomfortable, require frequent maintenan ...
Full textLink to itemCite
Journal ArticleEuropace · July 2, 2024
AIMS: Wearable cardioverter-defibrillators (WCDs) are indicated in patients at risk of sudden cardiac arrest who are not immediate candidates for implantable defibrillator therapy. Limitations of existing WCDs include poor compliance and high false alarm r ...
Full textLink to itemCite
Journal ArticleJ Am Geriatr Soc · April 2023
BACKGROUND: The contemporary uptake of lipid-lowering therapies (LLT), including more intensive treatment with high-intensity statins and non-statin LLT, among U.S. older adults (≥75 years old) with ASCVD is unknown. METHODS: In this multicenter retrospect ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 10, 2022
BACKGROUND: Preventive therapy among patients with established atherosclerotic cardiovascular disease (ASCVD) is generally underused. Whether new guideline recommendations and a focus on implementation have improved the use of high-intensity statins is unk ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · January 19, 2021
Background Evidence-based therapies are generally underused for cardiovascular risk reduction; however, less is known about contemporary patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. Methods and Results Pharmacy and med ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · December 2020
OBJECTIVES: This study sought to better understand the discrepant results of 2 trials of serelaxin on acute heart failure (AHF) and short-term mortality after AHF by analyzing causes of death of patients in the RELAX-AHF-2 (Efficacy, Safety and Tolerabilit ...
Full textLink to itemCite
Journal ArticleOpen Heart · October 1, 2019
Background: A variety of small mobile phone text-messaging interventions have indicated improvement in risk factors for cardiovascular disease (CVD). Yet the extent of this improvement and whether it impacts multiple risk factors together is uncertain. We ...
Full textCite
Journal ArticleAm Heart J · May 2019
Heart failure (HF) and diabetes mellitus (DM) are major public health issues that place significant burden on patients and health care systems. Patients with both HF and DM are at higher risk of adverse cardiovascular and HF outcomes than those with either ...
Full textLink to itemCite
Journal ArticleN Engl J Med · November 29, 2018
BACKGROUND: Patients who have had an acute coronary syndrome are at high risk for recurrent ischemic cardiovascular events. We sought to determine whether alirocumab, a human monoclonal antibody to proprotein convertase subtilisin-kexin type 9 (PCSK9), wou ...
Full textLink to itemCite
Journal ArticleLancet · October 27, 2018
BACKGROUND: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine t ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · June 12, 2018
As we enter the information age of health care, digital health technologies offer significant opportunities to optimize both clinical care delivery and clinical research. Despite their potential, the use of such information technologies in clinical care an ...
Full textLink to itemCite
Journal ArticleCirculation · August 22, 2017
Behavioral challenges are often present in human illness, so behavioral economics is increasingly being applied in healthcare settings to better understand why patients choose healthy or unhealthy behaviors. The application of behavioral economics to healt ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · May 2017
Acute heart failure (HF) is a major public health problem with substantial associated economic costs. Because most patients who present to hospitals are admitted irrespective of their level of risk, novel approaches to manage acute HF are needed, such as t ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · April 2017
Telehealth offers an innovative approach to improve heart failure care that expands beyond traditional management strategies. Yet the use of telehealth in heart failure is infrequent because of several obstacles. Fundamentally, the evidence is inconsistent ...
Full textLink to itemCite
Journal ArticleProg Cardiovasc Dis · 2017
Given the high prevalence of heart failure (HF) and the profound impact on morbid, mortality, and health care costs, strategies to improve outcomes and reduce cost have become progressively more attractive. Reducing HF hospitalizations as a study outcome h ...
Full textLink to itemCite
Journal ArticleBMJ Open · October 17, 2016
INTRODUCTION: Text message interventions have been shown to be effective in prevention and management of several non-communicable disease risk factors. However, the extent to which their effects might vary in different participants and settings is uncertai ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · October 6, 2016
BACKGROUND: Timely reperfusion after ST-elevation myocardial infarction (STEMI) improves survival. Guidelines recommend primary percutaneous coronary intervention (PPCI) within 90 minutes of arrival at a PCI-capable hospital. The alternative is fibrinolysi ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Card Fail · August 2016
BACKGROUND: Higher rates of obesity and heart failure have been observed in African Americans, but associations with mortality are not well-described. We examined intermediate and long-term clinical implications of obesity in African Americans and associat ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · June 2016
OBJECTIVES: This study assessed the comparative frequency of precipitating clinical factors leading to hospitalization among heart failure (HF) patients with reduced, borderline, and preserved ejection fraction (EF) BACKGROUND: There are few data assessing ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · March 1, 2016
BACKGROUND: In 2009, the Centers for Medicare & Medicaid Services (CMS) began publicly reporting 30-day hospital readmission rates for patients discharged with acute myocardial infarction (MI), heart failure (HF), or pneumonia. OBJECTIVES: This study asses ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · February 2016
BACKGROUND: In clinical trials, hydralazine-isosorbide dinitrate (H-ISDN) for heart failure with reduced ejection fraction reduced morbidity and mortality among black patients and patients with intolerance to angiotensin-converting enzyme inhibitors or ang ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · January 2016
BACKGROUND: Previous data demonstrate early follow-up (ie, within 7 days of discharge) after a hospitalization for heart failure is associated with a lower risk of readmission, yet is uncommon and varies widely across hospitals. Limited data exist on wheth ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · November 2015
OBJECTIVES: The authors sought to describe characteristics, treatments, and in-hospital outcomes of hospitalized heart failure (HF) patients stratified by etiology. BACKGROUND: Whether characteristics and outcomes of HF patients differ by cardiomyopathy et ...
Full textLink to itemCite
Journal ArticleCirculation · October 6, 2015
BACKGROUND: Guidelines for heart failure (HF) recommend prescription of guideline-directed medical therapy before hospital discharge; some of these therapies are included in publicly reported performance measures. The burden of new medications for individu ...
Full textLink to itemCite
Journal ArticleJ Card Fail · August 2015
The management of acute heart failure is shifting toward treatment approaches outside of a traditional hospital setting. Many heart failure providers are now treating patients in less familiar health care settings, such as acute care clinics, emergency dep ...
Full textOpen AccessLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · July 2015
BACKGROUND: There is significant variation in the delivery of evidence-based care for patients with heart failure (HF), but there is limited evidence defining the best methods to improve the quality of care. METHODS AND RESULTS: We performed a cluster-rand ...
Full textLink to itemCite
Journal ArticleAm Heart J · June 2015
BACKGROUND: Million Hearts is a national initiative to prevent 1 million heart attacks and strokes over 5 years by improving cardiovascular prevention. An important tool in the success of programs like Million Hearts is public ranking on the quality of pra ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · May 2015
BACKGROUND: An individual's socioeconomic status (SES) is associated with health outcomes and mortality, yet it is unknown whether accounting for SES can improve risk-adjustment models for 30-day outcomes among Centers for Medicare & Medicaid Services bene ...
Full textLink to itemCite
Journal ArticleJ Atr Fibrillation · May 1, 2015
Heart failure (HF) with reduced left ventricular function inflicts a large and growing burden of morbidity and mortality in the US and across the globe. One source of this burden is stroke. While it appears that HF itself may impose some risk of stroke, it ...
Link to itemCite
Journal ArticleJ Am Heart Assoc · April 22, 2015
BACKGROUND: Whether heart rate upon discharge following hospitalization for heart failure is associated with long-term adverse outcomes and whether this association differs between patients with sinus rhythm (SR) and atrial fibrillation (AF) have not been ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · March 2015
BACKGROUND: QRS prolongation is associated with adverse outcomes in mostly white populations, but its clinical significance is not well established for other groups. We investigated the association between QRS duration and mortality in African Americans. M ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J Cardiol · 2015
BACKGROUND: Because little was previously known about Asian-American patients with heart failure (HF), we compared clinical profiles, quality of care, and outcomes between Asian-American and non-Hispanic white HF patients using data from the American Heart ...
Full textLink to itemCite
Journal ArticleInt J Cardiol · December 20, 2014
BACKGROUND: Little is known about global patterns of critical care unit (CCU) care and the relationship with outcomes in patients with acute decompensated heart failure (ADHF). Whether a ward or a CCU admission is associated with better outcomes is unclear ...
Full textLink to itemCite
Journal ArticleAm Heart J · November 2014
BACKGROUND: Studies on outcomes among patients with heart failure (HF) with preserved left ventricular ejection fraction (HFpEF), borderline left ventricular ejection fraction (HFbEF), and reduced left ventricular ejection fraction (HFrEF) remain limited. ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · October 16, 2014
BACKGROUND: The degree to which outcomes following hospitalization for acute heart failure (HF) vary by racial and ethnic groups is poorly characterized. We sought to compare 30-day and 1-year rehospitalization and mortality rates for HF among 4 race/ethni ...
Full textOpen AccessLink to itemCite
Journal ArticleAm Heart J · September 2014
BACKGROUND: Million Hearts is a national initiative to prevent 1 million heart attacks and strokes over 5 years. The degree to which outpatient providers are controlling risk factors has not been fully described. METHODS: We examined adherence to the Milli ...
Full textLink to itemCite
Journal ArticleJMIR Mhealth Uhealth · May 1, 2014
BACKGROUND: The rapid growth in the number of mobile health applications could have profound significance in the prevention of disease or in the treatment of patients with chronic disease such as diabetes. OBJECTIVE: The objective of this study was to desc ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · April 15, 2014
OBJECTIVES: This study sought to examine trends in mortality, readmission, and costs among Medicare beneficiaries receiving ventricular assist devices (VADs) and associations between hospital-level procedure volume and outcomes. BACKGROUND: VADs are an opt ...
Full textLink to itemCite
Journal ArticleAm Heart J · March 2014
BACKGROUND: The relative impact of atrial fibrillation on early outcomes of patients with heart failure with reduced or preserved ejection fraction (EF) is unknown. METHODS: We conducted a retrospective cohort study of clinical registry data linked to Medi ...
Full textLink to itemCite
Journal ArticleJ Card Fail · January 2014
BACKGROUND: Postdischarge adherence and long-term persistence in the use of warfarin among patients with heart failure and atrial fibrillation without contraindications have not been fully described. METHODS AND RESULTS: We identified patients with heart f ...
Full textLink to itemCite
Journal ArticleAmerican heart journal · 2014
The relative impact of atrial fibrillation on early outcomes of patients with heart failure with reduced or preserved ejection fraction (EF) is unknown. We conducted a retrospective cohort study of clinical registry data linked to Medicare claims for patie ...
Cite
Journal ArticleJournal of Atrial Fibrillation · December 1, 2013
The risks and benefits of anticoagulation for patients with both heart failure and atrial fibrillation are unclear. We hypothesized that anticoagulation was associated with improved clinical outcomes of heart failure patients with atrial fibrillation indep ...
Cite
Journal ArticleClin Cardiol · December 2013
BACKGROUND: Effective warfarin thromboprophylaxis requires maintaining anticoagulation within the recommended international normalized ratio (INR) range. INR testing rates and associations between testing and outcomes are not well understood. HYPOTHESIS: I ...
Full textLink to itemCite
Journal ArticleAm Heart J · December 2013
BACKGROUND: In heart failure (HF), there are known differences in plasma B-type natriuretic peptide (BNP) levels between reduced and preserved ejection fraction (EF), but few HF studies have explored sex differences. We sought to evaluate the relationship ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · September 11, 2013
BACKGROUND: Dispensing data from Medicare Part D standalone prescription drug plans are now available, but characteristics of enrollees with heart failure have not been well described. METHODS AND RESULTS: We identified 81 874 patients with prevalent heart ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Card Fail · September 2013
BACKGROUND: The Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) randomly assigned 7,141 participants to nesiritide or placebo. Dyspnea improvement was more often reported in the nesiritide group, but there wer ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · July 2013
BACKGROUND: Hospital readmission is an important clinical outcome of patients with heart failure. Its relation to length of stay for the initial hospitalization is not clear. METHODS AND RESULTS: We used hierarchical modeling of data from a clinical trial ...
Full textLink to itemCite
Journal ArticleAm Heart J · June 2013
Numerous challenges-financial, regulatory, and cultural-are hindering US participation and performance in multinational clinical trials. Consequently, it is increasingly unclear how the results of these trials should be applied to American patients, practi ...
Full textLink to itemCite
Journal ArticleAm Heart J · June 2013
Sudden cardiac arrest (SCA) is one of the most impactful public health problems in the United States. Despite the progress made in reducing the number of cardiac deaths, the incidence of sudden cardiac death remains high. Studies of life-saving interventio ...
Full textLink to itemCite
Journal ArticleJ Card Fail · June 2013
BACKGROUND: Patients with heart failure are at higher risk for thromboembolic events, even in the absence of atrial fibrillation, but the effect of anticoagulation therapy on outcomes is uncertain. METHODS AND RESULTS: With data from a clinical registry li ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · June 2013
OBJECTIVES: The study sought to derive and validate risk-prediction tools from a large nationwide registry linked with Medicare claims data. BACKGROUND: Few clinical models have been developed utilizing data elements readily available in electronic health ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · May 1, 2013
BACKGROUND: Little is known as to whether long-term outcomes of acute ischemic stroke (AIS) vary by race/ethnicity. Using the American Heart Association Get With The Guidelines-Stroke registry linked with Medicare claims data set, we examined whether 30-da ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · March 1, 2013
BACKGROUND: Comparative effectiveness reviews offer a systematic method to critically appraise existing research and to identify unaddressed clinical areas in cardiovascular disease where significant morbidity, mortality, and variation in the use of resour ...
Full textLink to itemCite
Journal ArticleCirculation · December 11, 2012
BACKGROUND: The transition of scientific knowledge from discovery into practice is less than ideal. A key step in this translation occurs when presentations from major meetings are published in peer-reviewed literature, yet the completeness and speed of th ...
Full textLink to itemCite
Journal ArticleAm Heart J · June 2012
BACKGROUND: Patients hospitalized with heart failure (HF) have elevated B-type natriuretic peptide (BNP) levels and increased risk for thromboembolic events. Associations between BNP level and thromboembolic events in patients with HF without atrial fibril ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · March 1, 2012
Disease management programs that target patients with the highest risk of subsequent costs may help payers and providers control health care costs, but identifying these patients prospectively is challenging. We hypothesized that medical history and clinic ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · November 1, 2011
BACKGROUND: Composite indices of health care performance are an aggregation of underlying individual performance measures and are increasingly being used to rank hospitals. We sought to conduct an observational analysis to determine the influence of the op ...
Full textLink to itemCite
Journal ArticleHeart Fail Clin · October 2011
The selection of economic end points in acute decompensated heart failure (ADHF) clinical trials requires prospectively planned evaluations that are developed in tandem with clinical end points. Integrating economic end points with concrete clinical outcom ...
Full textLink to itemCite
Journal ArticleAm Heart J · August 2011
Sudden cardiac arrest (SCA) is the most common cause of death in the United States. Despite national guidelines, patients at risk for SCA often fail to receive evidence-based therapies. Racial and ethnic minorities and women are at particularly high risk f ...
Full textLink to itemCite
Journal ArticleAm Heart J · May 2011
BACKGROUND: Policy makers have proposed bundling payments for all heart failure (HF) care within 30 days of an HF hospitalization in an effort to reduce costs. Disease management (DM) programs can reduce costly HF readmissions but have not been economicall ...
Full textLink to itemCite
Journal ArticleCurr Opin Cardiol · May 2009
PURPOSE OF REVIEW: The incidence of heart failure is increasing due to an aging population and improved management of diseases that are precursors to ventricular dysfunction. The success of therapeutic advances has created a challenge for the next generati ...
Full textLink to itemCite